ALLISON SCADUTO: Open Payments
NPI 1053522813 · GREENBELT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,596 in 166 payments from 20 companies in 2025. Trend: 2023 $3,016 · 2024 $2,517 · 2025 $3,596
Food & beverage: $3,587Education: $10
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 29 | $599 |
| PFIZER INC. | 22 | $594 |
| ABBVIE INC. | 27 | $469 |
| Novartis Pharmaceuticals Corporation | 12 | $265 |
| Organon LLC | 8 | $227 |
| Amgen Inc. | 14 | $213 |
| Galderma Laboratories, L.P. | 8 | $199 |
| Janssen Biotech, Inc. | 8 | $190 |
| GENZYME CORPORATION | 6 | $172 |
| Incyte Corporation | 9 | $156 |
Products named: CIBINQO, Bimzelx, SKYRIZI, Otezla, DUPIXENT, COSENTYX, TREMFYA, VTAMA.
Industry payments across MD — which companies pay providers there.
